Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core LaboratoriesCLB -2.41%62 3-Year EBITDA Growth Rate is 6.40% as of Jun. 2026, which is 15% above its 10-year median of 5.55. GuruFocus rates CLB with a GF Score™ of 62/100 and a GF Value™ of $17.18 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 816 Oil & Gas companies, Core Laboratories ranks better than 60.29% on this metric.
During the past 12 months, Core Laboratories's average EBITDA Per Share Growth Rate was -6.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 6.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Core Laboratories was 55.30% per year. The lowest was -30.50% per year. And the median was 5.55% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Core Laboratories 3-Year EBITDA Growth Rate Related Terms
CLB vs EROK, OIS, NGS: 3-Year EBITDA Growth Rate Comparison
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories 3-Year EBITDA Growth Rate vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Core Laboratories's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 6.40% mean?
Core Laboratories (CLB) has a 3-Year EBITDA Growth Rate of 6.40% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Core Laboratories and its competitors. This is 15% above median its historical median of 5.55. According to the industry distribution chart, Core Laboratories ranks #324 out of 816 companies in the Oil & Gas industry, placing it in the top 39.7%.
Is Core Laboratories' 3-Year EBITDA Growth Rate too high?
Core Laboratories' current 3-Year EBITDA Growth Rate of 6.40% is 15% above median its 10-year median of 5.55. The Oil & Gas industry median 3-Year EBITDA Growth Rate is 0.85. Core Laboratories' value of 6.40% is 652.9% above this industry median. Based on the distribution chart, Core Laboratories ranks #324 out of 816 companies in the Oil & Gas industry, which is above the industry midpoint. Overall, Core Laboratories has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' 3-Year EBITDA Growth Rate compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #324 out of 816 companies for 3-Year EBITDA Growth Rate. This puts Core Laboratories in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.85. Core Laboratories' value of 6.40% is 652.9% above this benchmark. While the company's 10-year median is 5.55 vs. the industry median of 0.85, Core Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Oil & Gas company?
The median 3-Year EBITDA Growth Rate among Oil & Gas companies is 0.85, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current 3-Year EBITDA Growth Rate of 6.40% is 652.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Core Laboratories and its competitors. For the Oil & Gas industry, the median 3-Year EBITDA Growth Rate is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current 3-Year EBITDA Growth Rate is 6.40%, which is 15% above median its own 10-year median of 5.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Core Laboratories (CLB) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.18, compared to a current price of $10.95 — trading 36.3% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 6.40%, which is 15% above median its 10-year median of 5.55 and 652.9% above the Oil & Gas industry median of 0.85. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Core Laboratories (CLB), the current 3-Year EBITDA Growth Rate is 6.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of $10.95 is trading 36.3% below its estimated GF Value™ of $17.18.
GuruFocus considers Core Laboratories to be Significantly Undervalued.
Key valuation signals for CLB:
3-Year EBITDA Growth Rate: 6.40% (15% above median its 10-year median of 5.55)
GF Value™: $17.18 vs. price of $10.95 (36.3% below fair value)
Industry Position: 652.9% above the Oil & Gas median (#324 of 816)
No single metric tells the full story. See the CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for CLB
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLB has been successfully added to your 
